Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sanjay Maraboyina

TitleAssociate Professor
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentRadiation Oncology, College of Medicine
DivisionRadiation Oncology Faculty
Address4104 Outpatient Circle
Mail Slot # 771
Little Rock AR 72205
Phone501-603-8860
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Sanjay Maraboyina is an Assistant Professor in the Radiation Oncology Department at the UAMS College of Medicine, and is board certified by the American Board of Radiology. He received his medical degree from Drexel University College of Medicine. Dr. Maraboyina went on to complete an internship in internal medicine at Christ Hospital in Cincinnati, Ohio and a Radiation Oncology residency at the University of Kansas Medical Center. He also completed a Prostate Brachytherapy Scholarship at the MD Anderson Cancer Center in Houston.Dr. Maraboyina has done research work on a number of topics, including the effects of brachytherapy for prostate cancer and the effects of insulin and glucocorticoids on the cell cycle. His publications include abstracts in the International Journal of Radiation Oncology, the official journal of the American Society for Radiation Oncology (ASTRO), as well as presenting an abstact at the American Society of Hematology Annual Meeting.


    Collapse Research 
    Collapse research activities and funding
    NRG-GU012     (MARABOYINA, SANJAY)May 17, 2023 - May 16, 2033
    NRG Oncology Foundation
    NRG-GU012 - Randomized Phase II Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Unresected Renal Cell Carcinoma (RCC) Receiving Immunotherapy (SAMURAI)
    Role: Principal Investigator
    NRG-GU009     (MARABOYINA, SANJAY)Sep 15, 2021 - Sep 14, 2031
    NRG Oncology Foundation
    Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk with Radiation (PREDICT-RT*) (273360)
    Role: Principal Investigator
    PROTOCOL NRG-LU005     (MARABOYINA, SANJAY)Nov 15, 2019
    NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
    No FP attached
    Role: Principal Investigator
    PROTOCOLNRG-LU005     (MARABOYINA, SANJAY)Nov 15, 2019
    NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
    NRG-LU005, Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab (260043)
    Role: Principal Investigator
    NRG - GU005     (MARABOYINA, SANJAY)Apr 20, 2018
    NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
    No FP attached
    Role: Principal Investigator
    NRG-GU005     (MARABOYINA, SANJAY)Apr 20, 2018
    NIH/Nat. Cancer Institute - Pass Through: NRG Oncology Foundation
    NRG-GU005: Phase III IGRT and SBRT vs IGRT and Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Jackson JC, Sanchez D, Johns AC, Campbell MT, Aydin AM, Gokden N, Maraboyina S, Muesse JL, Ward JF, Pisters LL, Zacharias NM, Guo CC, Tu SM. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. J Clin Med. 2024 Jun 12; 13(12). PMID: 38929965.
      View in: PubMed
    2. Tu SM, Chen JZ, Singh SR, Maraboyina S, Gokden N, Hsu PC, Langford T. Stem Cell Theory of Cancer: Clinical Implications for Cellular Metabolism and Anti-Cancer Metabolomics. Cancers (Basel). 2024 Jan 31; 16(3). PMID: 38339375.
      View in: PubMed
    3. Tu SM, Aydin AM, Maraboyina S, Chen Z, Singh S, Gokden N, Langford T. Stem Cell Origin of Cancer: Clinical Implications for Cancer Immunity and Immunotherapy. Cancers (Basel). 2023 Nov 13; 15(22). PMID: 38001645.
      View in: PubMed
    4. Nissen C, Ying J, Kalantari F, Patel M, Prabhu AV, Kesaria A, Kim T, Maraboyina S, Harrell L, Xia F, Lewis GD. A Prospective Study Measuring Resident and Faculty Contour Concordance: A Potential Tool for Quantitative Assessment of Residents' Performance in Contouring and Target Delineation in Radiation Oncology Residency. J Am Coll Radiol. 2024 Mar; 21(3):464-472. PMID: 37844655.
      View in: PubMed
    5. Boria AJ, Narayanasamy G, Bimali M, Maraboyina S, Kalantari F, Sabouri P, Su Z. Cleaning the dose falloff with low modulation in SBRT lung plans. Biomed Phys Eng Express. 2023 05 04; 9(4). PMID: 37140156.
      View in: PubMed
    6. Tu SM, Aydin AM, Maraboyina S, Chen Z, Singh S, Gokden N, Langford T. Stem Cell Origin of Cancer: Implications of Oncogenesis Recapitulating Embryogenesis in Cancer Care. Cancers (Basel). 2023 Apr 27; 15(9). PMID: 37173982.
      View in: PubMed
    7. Hallgren E, Ayers BL, Moore R, Purvis RS, McElfish PA, Maraboyina S, Bryant-Smith G. Facilitators and barriers to employment for rural women cancer survivors. J Cancer Surviv. 2023 10; 17(5):1338-1346. PMID: 35142993.
      View in: PubMed
    8. Patel MA, Fazli Y, Sivakumar S, Dennis C, Maraboyina S, Prabhu AV, Kim T. Brachytherapy vs external beam therapy among NSCLC patients undergoing limited surgical resection. J Cancer Res Clin Oncol. 2021 Mar; 147(3):853-861. PMID: 32940781.
      View in: PubMed
    9. Patel M, Bimali M, Howie C, McClain P, Mehta S, Harari M, Hans HS, Agarwal A, Pederson A, Maraboyina S, Kim T. The Role of Radiotherapy Among Patients With Prostate Ductal Adenocarcinoma. Clin Genitourin Cancer. 2021 02; 19(1):e41-e50. PMID: 33616071.
      View in: PubMed
    10. Patel M, Nowsheen S, Maraboyina S, Xia F. The role of poly(ADP-ribose) polymerase inhibitors in the treatment of cancer and methods to overcome resistance: a review. Cell Biosci. 2020; 10:35. PMID: 32180937.
      View in: PubMed
    11. Patel M, Li C, Aronson JH, Howie CM, Maraboyina S, Prabhu AV, Kim T. The effect of post mastectomy radiation therapy on survival in breast cancer patients with N1mic disease. Breast. 2020 Jun; 51:50-56. PMID: 32213441.
      View in: PubMed
    12. Patel M, Im J, Ivy A, Maraboyina S, Kim T. The epidemiology and role of surgery in the treatment of urethral clear cell carcinoma. Int Urol Nephrol. 2020 Jan; 52(1):51-57. PMID: 31555949.
      View in: PubMed
    13. Atiq SO, Atiq OO, Atiq MO, Phillips KC, Jacks BB, Moreno M, Maraboyina S, Atiq OT. The Role of Immunotherapy and Radiation Therapy in Tumor Chemosensitivity in Advanced Head and Neck Cancer. Am J Case Rep. 2018 Oct 18; 19:1241-1244. PMID: 30333474.
      View in: PubMed
    14. Narayanasamy G, Desai D, Maraboyina S, Penagaricano J, Zwicker R, Johnson EL. A Dose Falloff Gradient Study in RapidArc Planning of Lung Stereotactic Body Radiation Therapy. J Med Phys. 2018 Jul-Sep; 43(3):147-154. PMID: 30305771.
      View in: PubMed
    15. Narayanasamy G, Desai D, Morrill S, Zhang X, Galhardo E, Maraboyina S, Penagaricano J. Technical Note: A planning technique to lower normal tissue toxicity in lung SBRT plans based on two likely dependent RTOG metrics. Med Phys. 2018 May; 45(5):2325-2328. PMID: 29480933.
      View in: PubMed
    16. Zhang X, Rong Y, Morrill S, Fang J, Narayanasamy G, Galhardo E, Maraboyina S, Croft C, Xia F, Penagaricano J. Robust optimization in lung treatment plans accounting for geometric uncertainty. J Appl Clin Med Phys. 2018 May; 19(3):19-26. PMID: 29524301.
      View in: PubMed
    17. Narayanasamy G, Zhang X, Meigooni A, Paudel N, Morrill S, Maraboyina S, Peacock L, Penagaricano J. Therapeutic benefits in grid irradiation on Tomotherapy for bulky, radiation-resistant tumors. Acta Oncol. 2017 Aug; 56(8):1043-1047. PMID: 28270018.
      View in: PubMed
    18. Ram TS, Badkul R, Maraboyina S, Wang F. A comparative study to evaluate the efficacy of on board imaging with cone beam CT using target registration in patients with lung tumors undergoing stereotactic body radiation therapy and comparison with ExacTrac using skeletal registration on Novalis Tx. J Cancer Res Ther. 2011 Jul-Sep; 7(3):304-7. PMID: 22044812.
      View in: PubMed
    Maraboyina's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (57) concept(s)
    _
    Co-Authors Expand Description
    See all (25) people
    _
    Similar People Expand Description
    See all (35) people
    _
    Same Department Expand Description
    Search Department